Dr. Martens plc (the 'Company')
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
The Company announces that it was notified on 24 September 2024 of the following transaction in the Company's Ordinary 1p shares (the 'shares') undertaken by a director / person discharging managerial responsibility ('PDMRs'):
- In order to effect a 'Bed and ISA' transaction, Robyn Perriss, Independent Non-Executive Director, sold 89,054 ordinary shares of
1 pence each in the Company ('Ordinary Shares') at a price of£0.515 per Ordinary Share and then repurchased 89,054 Ordinary Shares into her ISA at a price of£0.5155 per Ordinary Share. Following these transactions, Robyn's overall beneficial interest in the Company's Ordinary Shares remains unchanged at 99,328 Ordinary Shares.
The relevant notifications, set out below, are provided in accordance with the requirements of Article 19 of the
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
a) |
Name |
Robyn Perriss |
||||||
2 |
Reason for the notification |
|||||||
a) |
Position/status |
PDMR (Non-Executive Director) |
||||||
b) |
Initial notification/Amendment |
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name |
Dr. Martens plc |
||||||
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of
|
||||||
b) |
Nature of the transaction |
Sale of Ordinary Shares in order to effect a |
||||||
c) |
Price(s) and volume(s) |
|
||||||
d) |
Aggregated information
|
Single transaction |
||||||
e) |
Date of the transaction |
24 September 2024 |
||||||
f) |
Place of the transaction |
London Stock Exchange (XLON) |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
a) |
Name |
Robyn Perriss |
||||||
2 |
Reason for the notification |
|||||||
a) |
Position/status |
PDMR (Non-Executive Director) |
||||||
b) |
Initial notification/Amendment |
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name |
Dr. Martens plc |
||||||
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of
|
||||||
b) |
Nature of the transaction |
Purchase of Ordinary Shares to complete a |
||||||
c) |
Price(s) and volume(s) |
|
||||||
d) |
Aggregated information
|
Single transaction |
||||||
e) |
Date of the transaction |
24 September 2024 |
||||||
f) |
Place of the transaction |
London Stock Exchange (XLON) |
For further information please contact:
Paul Rolling
Assistant Company Secretary
paul.rolling@drmartens.com
+4475 8424 3562
Bethany Barnes
Director of Investor Relations
bethany.barnes@drmartens.com
+4478 2518 7465
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.